Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Zeitschrift Fur Gastroenterologie|July 23, 2026
Characterization of a Northern German Primary Biliary Cholangitis CohortHeike Bantel, Yunus Fatih Kader, Katharina John, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2015
Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patientsKatharina John, Imme Rösner, Ulrich Keilholz, et al.
The Science of the Total Environment|January 14, 2020
Earthworms offset straw-induced increase of greenhouse gas emission in upland rice productionKatharina John, Baldur Janz, Ralf Kiese, et al.
The Journal of Infectious Diseases|October 28, 2015
Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus InfectionFranziska Wandrer, Christine S Falk, Katharina John, et al.
Journal of Cell Science|April 9, 2010
Differential role of Rab proteins in ciliary trafficking: Rab23 regulates smoothened levelsChristopher Boehlke, Mikhail Bashkurov, Andrea Buescher, et al.
The Journal of Infectious Diseases|June 7, 2026
Concomitant liver steatosis in chronic HBV infection is linked to a distinct cytokine profile and reduced viral loadKatharina John, Marie-Louise Voss, Sherin Al Aoua, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2023
Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patientsMartin Franck, Katharina John, Sherin Al Aoua, et al.
Cell Death & Disease|July 27, 2021
BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatmentStephanie Busche, Katharina John, Franziska Wandrer, et al.
Hepatology (Baltimore, Md.)|June 11, 2014
MicroRNAs play a role in spontaneous recovery from acute liver failureKatharina John, Johannes Hadem, Till Krech, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 22, 2025
Limitations of Guideline-Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug TreatmentsMartin Franck, Katharina John, Monika Rau, et al.
Pageof 3